These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 17021752)

  • 21. Extra-axial chordoma. Report of a case with immunohistochemical study.
    Cesinaro AM; Maiorana A; Collina G; Fano RA
    Pathologica; 1993; 85(1100):755-60. PubMed ID: 7513394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
    Oakley GJ; Fuhrer K; Seethala RR
    Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
    Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
    J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical and electron microscopic studies on intracranial chordomas: difference between typical chordomas and chondroid chordomas.
    Niwa J; Hashi K; Minase T
    Noshuyo Byori; 1994; 11(1):15-21. PubMed ID: 7512865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
    Pamir MN; Ozduman K
    Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of immunohistochemical study in the diagnosis and differential diagnosis of chordoma].
    Xu Y; Xu K; Ji P
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):435-7. PubMed ID: 8697996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies.
    Miettinen M; Lehto VP; Dahl D; Virtanen I
    Am J Pathol; 1983 Aug; 112(2):160-9. PubMed ID: 6192722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications.
    Mitchell A; Scheithauer BW; Unni KK; Forsyth PJ; Wold LE; McGivney DJ
    Cancer; 1993 Nov; 72(10):2943-9. PubMed ID: 7693324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chordoma. Antibodies to epithelial membrane antigen and carcinoembryonic antigen in differential diagnosis.
    Miettinen M
    Arch Pathol Lab Med; 1984 Nov; 108(11):891-2. PubMed ID: 6548365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
    Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
    Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
    Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinicopathological and immunohistochemical study of 34 cases of chordoma].
    Hu Y; Gao Y; Zhang X
    Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):142-4. PubMed ID: 9275666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Magnetic resonance (MR) imaging of chordoma and chondroma in the skull base--differential diagnosis by IR sequence].
    Tashiro T; Inoue Y; Nemoto Y; Shakudo M; Mochizuki K; Yahata S; Tada T; Hata M; Oda J; Onoyama Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):589-93. PubMed ID: 1508632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunohistochemical studies of chordomas and choroid tumors].
    Lossnitzer A; Zotter S; Kunze KD
    Zentralbl Allg Pathol; 1986; 132(3):193-6. PubMed ID: 2431555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-grade myxoid chondrosarcoma of the temporal bone: differential diagnosis and report of two cases.
    Reid CB; Fagan PA; Turner J
    Am J Otol; 1994 May; 15(3):419-22. PubMed ID: 8579153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parachordoma is not distinguishable from axial chordoma using immunohistochemistry.
    Scolyer RA; Bonar SF; Palmer AA; Barr EM; Wills EJ; Stalley P; Schatz J; Soper J; Li LX; McCarthy SW
    Pathol Int; 2004 May; 54(5):364-70. PubMed ID: 15086843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?
    Douis H; Parry M; Vaiyapuri S; Davies AM
    Eur Radiol; 2018 Jan; 28(1):398-409. PubMed ID: 28695356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chondroid chordoma versus low-grade chondrosarcoma of the base of the skull: can immunohistochemistry resolve the controversy?
    Ishida T; Dorfman HD
    J Neurooncol; 1994; 18(3):199-206. PubMed ID: 7525890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chordomas: a histological and immunohistochemical study of cases with and without recurrent tumors.
    Sell M; Sampaolo S; Di Lorio G; Theallier A
    Clin Neuropathol; 2004; 23(6):277-85. PubMed ID: 15584212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.